novo nordisk glp 1 drug With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins Novo Nordisk's oral GLP-1 drug
Description
As these drugs are being used by an increasing group of fertile women, it is expected that a few of them will get pregnant and data on the safety of continuation would prove valuable
Do not double up on doses to compensate, as this can intensify side effects without accelerating benefits
Exploratory analyses highlighted a link between treatment with tirzepatide and amelioration of biomarkers associated with inflammation and atherosclerotic cardiovascular diseases [84]

177: 3541 [DOI] [PubMed] [Google Scholar] 129.Tsukiyama K, Yamada Y, Yamada C, et al

Accessed October 30, 2025

Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al